VHL and nonpapillary renal cell carcinoma: Furthermore, bexarotene, an RXR agonist, which restores ciliogenesis in ccRCC cells devoid of VHL in a mechanism involving AURKA reduction, attenuates incidence of ccRCC tumor xenografts in mice [177].